{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:26:06Z","timestamp":1792038366844,"version":"4.4.0"},"reference-count":30,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Contrary to prior case reports that described occasional clinical failures with cefazolin for methicillin-susceptible\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Staphylococcus aureus<\/jats:named-content>\n            (MSSA) infections, recent studies have demonstrated no difference in outcomes between cefazolin and antistaphylococcal penicillins for the treatment of MSSA bacteremia. While promising, these studies described low frequencies of high-inoculum infections, such as endocarditis. This retrospective study compares clinical outcomes of cefazolin versus oxacillin for complicated MSSA bacteremia at two tertiary care hospitals between January 2008 and June 2012. Fifty-nine patients treated with cefazolin and 34 patients treated with oxacillin were included. Osteoarticular (41%) and endovascular (20%) sources were the predominant sites of infection. The rates of clinical cure at the end of therapy were similar between cefazolin and oxacillin (95% versus 88%;\n            <jats:italic>P<\/jats:italic>\n            = 0.25), but overall failure at 90 days was higher in the oxacillin arm (47% versus 24%;\n            <jats:italic>P<\/jats:italic>\n            = 0.04). Failures were more likely to have received surgical interventions (63% versus 40%;\n            <jats:italic>P<\/jats:italic>\n            = 0.05) and to have an osteoarticular source (57% versus 33%;\n            <jats:italic>P<\/jats:italic>\n            = 0.04). Failures also had a longer duration of bacteremia (7 versus 3 days;\n            <jats:italic>P<\/jats:italic>\n            = 0.0002), which was the only predictor of failure. Antibiotic selection was not predictive of failure. Rates of adverse drug events were higher in the oxacillin arm (30% versus 3%;\n            <jats:italic>P<\/jats:italic>\n            = 0.0006), and oxacillin was more frequently discontinued due to adverse drug events (21% versus 3%;\n            <jats:italic>P<\/jats:italic>\n            = 0.01). Cefazolin appears similar to oxacillin for the treatment of complicated MSSA bacteremia but with significantly improved safety. The higher rates of failure with oxacillin may have been confounded by other patient factors and warrant further investigation.\n          <\/jats:p>","DOI":"10.1128\/aac.02800-14","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T04:05:22Z","timestamp":1402977922000},"page":"5117-5124","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":112,"title":["Comparison of Cefazolin versus Oxacillin for Treatment of Complicated Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus"],"prefix":"10.1128","volume":"58","author":[{"given":"Julius","family":"Li","sequence":"first","affiliation":[{"name":"South Texas Veterans Health Care System, San Antonio, Texas, USA"},{"name":"The University of Texas at Austin College of Pharmacy, Austin, Texas, USA"},{"name":"Pharmacotherapy Education and Research Center, University of Texas Health Sciences Center San Antonio, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"Echevarria","sequence":"additional","affiliation":[{"name":"South Texas Veterans Health Care System, San Antonio, Texas, USA"},{"name":"The University of Texas at Austin College of Pharmacy, Austin, Texas, USA"},{"name":"Pharmacotherapy Education and Research Center, University of Texas Health Sciences Center San Antonio, San Antonio, Texas, USA"},{"name":"Department of Medicine, Division of Infectious Diseases, University of Texas Health Sciences Center San Antonio, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrel W.","family":"Hughes","sequence":"additional","affiliation":[{"name":"The University of Texas at Austin College of Pharmacy, Austin, Texas, USA"},{"name":"Pharmacotherapy Education and Research Center, University of Texas Health Sciences Center San Antonio, San Antonio, Texas, USA"},{"name":"Department of Pharmacy, University Health System, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Cadena","sequence":"additional","affiliation":[{"name":"South Texas Veterans Health Care System, San Antonio, Texas, USA"},{"name":"Department of Medicine, Division of Infectious Diseases, University of Texas Health Sciences Center San Antonio, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason E.","family":"Bowling","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of Texas Health Sciences Center San Antonio, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"James S.","family":"Lewis","sequence":"additional","affiliation":[{"name":"The University of Texas at Austin College of Pharmacy, Austin, Texas, USA"},{"name":"Pharmacotherapy Education and Research Center, University of Texas Health Sciences Center San Antonio, San Antonio, Texas, USA"},{"name":"Department of Medicine, Division of Infectious Diseases, University of Texas Health Sciences Center San Antonio, San Antonio, Texas, USA"},{"name":"Department of Pharmacy, University Health System, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.165564"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1977.03270330059022"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/128.Supplement_2.S386"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/430833"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/379021"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00317-09"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00052-12"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00485-11"},{"key":"e_1_3_1_10_2","article-title":"Antibiotic stewardship involving anti-staphylococcal beta-lactams at a Veterans Affairs hospital","author":"Echevarria K","year":"2012","unstructured":"EchevarriaKChildsLOatesECadenaJ. 2012. Antibiotic stewardship involving anti-staphylococcal beta-lactams at a Veterans Affairs hospital. Abstr. IDWeek 2012, abstr 34750.","journal-title":"Abstr. IDWeek 2012, abstr 34750"},{"key":"e_1_3_1_11_2","article-title":"Clinical and financial impact of the replacement of oxacillin with cefazolin for MSSA infections","author":"Lewis JS","year":"2012","unstructured":"LewisJSIIBowlingJELaurelYJorgensenJH. 2012. Clinical and financial impact of the replacement of oxacillin with cefazolin for MSSA infections. Abstr. IDWeek 2012, abstr 739.","journal-title":"Abstr. IDWeek 2012, abstr 739"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa053783"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03425.x"},{"key":"e_1_3_1_14_2","article-title":"Treatment outcomes of cefazolin versus oxacillin for high burden methicillin-sensitive Staphylococcus aureus (MSSA) bloodstream infections (BSI)","author":"Nevrekar S","year":"2013","unstructured":"NevrekarSRhodesNCrankCScheetzMHPavellASegretiJWangS. 2013. Treatment outcomes of cefazolin versus oxacillin for high burden methicillin-sensitive Staphylococcus aureus (MSSA) bloodstream infections (BSI). Abstr. IDWeek 2013, abstr 1731.","journal-title":"Abstr. IDWeek 2013, abstr 1731"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809202600724"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/338047"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02032-13"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu301"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/54.10.1176"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/420939"},{"key":"e_1_3_1_21_2","article-title":"Effects of an intervention to substitute cefazolin for nafcillin in selected cases of methicillin-susceptible Staphylococcus aureus bacteremia","author":"Huang M","year":"2013","unstructured":"HuangMKnepperBHaasMJenkinsT. 2013. Effects of an intervention to substitute cefazolin for nafcillin in selected cases of methicillin-susceptible Staphylococcus aureus bacteremia. Abstr. IDWeek 2013, abstr 1017.","journal-title":"Abstr. IDWeek 2013, abstr 1017"},{"key":"e_1_3_1_22_2","article-title":"Costs and outcomes for children with methicillin-susceptible Staphylococcus aureus osteoarticular infections with bacteremia","author":"Nuibe A","year":"2013","unstructured":"NuibeAOlsonJHershAStockmannCSandersonSPaviaAThorellEA. 2013. Costs and outcomes for children with methicillin-susceptible Staphylococcus aureus osteoarticular infections with bacteremia. Abstr. IDWeek 2013, abstr 421.","journal-title":"Abstr. IDWeek 2013, abstr 421"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt254"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00856-13"},{"key":"e_1_3_1_25_2","article-title":"Clinical implication of cefazolin inoculum effect on methicillin-susceptible Staphylococcus aureus bacteremia","author":"Lee S","year":"2013","unstructured":"LeeSKwonKTKimHIChangHHLeeJMChoePGParkWBKimNJOhMDKimSW. 2013. Clinical implication of cefazolin inoculum effect on methicillin-susceptible Staphylococcus aureus bacteremia. Abstr. IDWeek 2013, abstr 375.","journal-title":"Abstr. IDWeek 2013, abstr 375"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.24.3012"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e318289ff1e"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365540500372846"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2010.02.026"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.17.1861"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.04.011"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02800-14","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02800-14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:46:40Z","timestamp":1645483600000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02800-14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1128\/AAC.02800-14"],"URL":"https:\/\/doi.org\/10.1128\/aac.02800-14","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"2014-03-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-06-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-08-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}